source
- ADARx raises $446 million in one of 2026's largest biotech IPOs as City Therapeutics plans its own listingADARx Pharmaceuticals completed an initial public offering that raised about $446.3 million, exceeding the company’s original target. The shares were priced at $17 each, with 26.25 million shares…
- Five candidates vie for WHO director‑general role as agency faces US funding pullback and tighter global health budgetsAt least five candidates are in the running to become the next director‑general of the World Health Organization, a race analysts say could be the most consequential in the agency's recent history.…